2023 Q2 Form 10-Q Financial Statement

#000139390523000229 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $1.409M $1.388M $2.096M
YoY Change -42.69% -33.75% 82.33%
Cost Of Revenue $609.3K $768.7K $1.348M
YoY Change -45.51% -42.96% 334.46%
Gross Profit $800.1K $619.7K $748.0K
YoY Change -40.34% -17.15% -10.86%
Gross Profit Margin 56.77% 44.64% 35.69%
Selling, General & Admin $400.4K $586.3K $1.712M
YoY Change -79.59% -65.75% 42.16%
% of Gross Profit 50.05% 94.61% 228.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.171K $9.781K $71.05K
YoY Change -87.0% -86.23% 23.48%
% of Gross Profit 1.15% 1.58% 9.5%
Operating Expenses $1.002M $1.287M $1.712M
YoY Change -48.91% -24.83% 42.16%
Operating Profit -$202.4K -$667.1K -$964.0K
YoY Change -67.43% -30.8% 164.03%
Interest Expense -$598.3K $157.5K -$1.257M
YoY Change -287.19% -112.53% 176.25%
% of Operating Profit
Other Income/Expense, Net -$326.1K -$314.9K $11.81K
YoY Change -5446.66% -2766.33%
Pretax Income -$528.5K -$982.0K -$2.078M
YoY Change 185.1% -52.75% 335.14%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$549.8K -$667.1K -$1.586M
YoY Change -2780.64% -57.93% 295.06%
Net Earnings / Revenue -39.01% -48.05% -75.66%
Basic Earnings Per Share -$0.02 -$0.05 -$0.60
Diluted Earnings Per Share -$0.02 -$0.05 -$790.10
COMMON SHARES
Basic Shares Outstanding 12.29M shares 6.158B shares 4.014M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $146.8K $114.0K $595.9K
YoY Change -70.3% -80.87% -28.3%
Cash & Equivalents $146.8K $114.0K $595.9K
Short-Term Investments
Other Short-Term Assets $2.600K $2.600K $14.37K
YoY Change -96.98% -81.91% -95.95%
Inventory $2.881M $2.886M $3.111M
Prepaid Expenses
Receivables $132.1K $160.0K $82.74K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.163M $3.163M $3.804M
YoY Change -15.04% -16.86% 5.36%
LONG-TERM ASSETS
Property, Plant & Equipment $36.11K $45.28K $157.4K
YoY Change -70.68% -71.23% -2.02%
Goodwill $5.681M $5.681M
YoY Change
Intangibles $148.3K $208.8K
YoY Change
Long-Term Investments $6.600K $6.600K $6.600K
YoY Change 0.0% 0.0% 13.21%
Other Assets
YoY Change
Total Long-Term Assets $5.977M $6.052M $6.296M
YoY Change -3.62% -3.87% 67.33%
TOTAL ASSETS
Total Short-Term Assets $3.163M $3.163M $3.804M
Total Long-Term Assets $5.977M $6.052M $6.296M
Total Assets $9.139M $9.215M $10.10M
YoY Change -7.91% -8.76% 36.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.682M $1.880M $1.740M
YoY Change -4.88% 8.06% 16.56%
Accrued Expenses $1.101M $987.5K $454.1K
YoY Change 149.59% 117.46% 126.87%
Deferred Revenue
YoY Change
Short-Term Debt $1.051M $977.2K $1.337M
YoY Change 10.81% -26.93% -52.52%
Long-Term Debt Due $768.7K $818.7K $699.0K
YoY Change -2.49% 17.12%
Total Short-Term Liabilities $5.266M $4.916M $5.045M
YoY Change 27.44% -2.55% -9.59%
LONG-TERM LIABILITIES
Long-Term Debt $260.2K $261.3K $263.0K
YoY Change -0.66% -0.64% 75.36%
Other Long-Term Liabilities $72.11K $77.99K $20.37K
YoY Change 353.24% 282.87% -96.2%
Total Long-Term Liabilities $332.3K $339.3K $283.4K
YoY Change 19.61% 19.73% -58.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.266M $4.916M $5.045M
Total Long-Term Liabilities $332.3K $339.3K $283.4K
Total Liabilities $5.598M $5.255M $4.278M
YoY Change 77.52% 22.85% -31.73%
SHAREHOLDERS EQUITY
Retained Earnings -$20.84M -$20.28M
YoY Change
Common Stock $741.00 $123.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.064M $5.503M $5.822M
YoY Change
Total Liabilities & Shareholders Equity $9.139M $9.215M $10.10M
YoY Change -7.91% -8.76% 36.98%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$549.8K -$667.1K -$1.586M
YoY Change -2780.64% -57.93% 295.06%
Depreciation, Depletion And Amortization $9.171K $9.781K $71.05K
YoY Change -87.0% -86.23% 23.48%
Cash From Operating Activities -$31.07K -$656.5K -$1.071M
YoY Change -93.87% -38.72% 326.27%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.900K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$4.900K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 63.94K $311.1K 573.9K
YoY Change -84.22% -45.79% -45.46%
NET CHANGE
Cash From Operating Activities -31.07K -$656.5K -1.071M
Cash From Investing Activities 0.000 -$4.900K
Cash From Financing Activities 63.94K $311.1K 573.9K
Net Change In Cash 32.87K -$350.3K $0.00
YoY Change -132.42% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$31.07K -$656.5K -$1.071M
Capital Expenditures $0.00 $4.900K $0.00
Free Cash Flow -$31.07K -$661.4K -$1.071M
YoY Change -93.87% -38.26% 407.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-963957 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-150029
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BERGIO INTERNATIONAL, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1338257
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12 Daniel Road E.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfield
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07004
CY2023Q1 dei City Area Code
CityAreaCode
973
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
227-3230
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12293772 shares
CY2023Q1 us-gaap Cash
Cash
113972 usd
CY2022Q4 us-gaap Cash
Cash
464248 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
160009 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119931 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2885975 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2855585 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2600 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3162556 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3440464 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45283 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50164 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5681167 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5681167 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
208830 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
269319 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110201 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24595 usd
CY2022Q4 fil Convertible Series C Preferred Stock Value
ConvertibleSeriesCPreferredStockValue
0 usd
CY2023Q1 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
6603 usd
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
6603 usd
CY2023Q1 us-gaap Assets
Assets
9214640 usd
CY2022Q4 us-gaap Assets
Assets
9472312 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1879864 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1851432 usd
CY2023Q1 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
11582 usd
CY2023Q1 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
349264 usd
CY2022Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
319640 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
818656 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
702504 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
38864 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
19324 usd
CY2023Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
1282569 usd
CY2022Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
1072089 usd
CY2023Q1 fil Advances From Ceo And Accrued Interest
AdvancesFromCeoAndAccruedInterest
261810 usd
CY2022Q4 fil Advances From Ceo And Accrued Interest
AdvancesFromCeoAndAccruedInterest
142854 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
119519 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
108594 usd
CY2023Q1 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
133140 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
7914 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32216 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18072 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4915902 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4254005 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261344 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
259496 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77985 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6524 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
339329 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
266020 usd
CY2023Q1 us-gaap Liabilities
Liabilities
5255231 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4520025 usd
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
317000 usd
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
0 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 fil Convertible Series B Preferred Stock Value
ConvertibleSeriesBPreferredStockValue
0 usd
CY2022Q4 fil Convertible Series B Preferred Stock Value
ConvertibleSeriesBPreferredStockValue
0 usd
CY2023Q1 fil Convertible Series C Preferred Stock Value
ConvertibleSeriesCPreferredStockValue
0 usd
CY2023Q1 fil Convertible Series D Preferred Stock Value
ConvertibleSeriesDPreferredStockValue
10 usd
CY2022Q4 fil Convertible Series D Preferred Stock Value
ConvertibleSeriesDPreferredStockValue
13 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12319522 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12316954 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
123 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
123 usd
CY2023Q1 fil Common Stock Issuable Nyi
CommonStockIssuableNYI
1000000 shares
CY2023Q1 fil Common Stock Issuable Value
CommonStockIssuableValue
10 usd
CY2022Q4 fil Common Stock Issuable Value
CommonStockIssuableValue
10 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25785891 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26102888 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20283316 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19605358 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5502718 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6497676 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-1860309 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-1545389 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3642409 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4952287 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9214640 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9472312 usd
CY2023Q1 fil Net Revenues
NetRevenues
1388363 usd
CY2022Q1 fil Net Revenues
NetRevenues
1956501 usd
CY2023Q1 fil Revenues From Related Parties
RevenuesFromRelatedParties
0 usd
CY2022Q1 fil Revenues From Related Parties
RevenuesFromRelatedParties
139050 usd
CY2023Q1 us-gaap Revenues
Revenues
1388363 usd
CY2022Q1 us-gaap Revenues
Revenues
2095551 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
768661 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1246737 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
619702 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
848814 usd
CY2023Q1 fil Selling And Marketing Expenses
SellingAndMarketingExpenses
360180 usd
CY2022Q1 fil Selling And Marketing Expenses
SellingAndMarketingExpenses
721104 usd
CY2023Q1 fil Professional And Consulting Expenses
ProfessionalAndConsultingExpenses
532274 usd
CY2022Q1 fil Professional And Consulting Expenses
ProfessionalAndConsultingExpenses
553952 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
168202 usd
CY2022Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
280018 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
226127 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
257697 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1286783 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1812771 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-667081 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
157458 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1095233 usd
CY2023Q1 fil Derivative Expense
DerivativeExpense
0 usd
CY2022Q1 fil Derivative Expense
DerivativeExpense
16900 usd
CY2023Q1 fil Amortization Of Debt Discount And Deferred Financing Cost
AmortizationOfDebtDiscountAndDeferredFinancingCost
-19541 usd
CY2022Q1 fil Amortization Of Debt Discount And Deferred Financing Cost
AmortizationOfDebtDiscountAndDeferredFinancingCost
-317840 usd
CY2023Q1 fil Loss From Foreign Currency Transactions
LossFromForeignCurrencyTransactions
-1744 usd
CY2022Q1 fil Loss From Foreign Currency Transactions
LossFromForeignCurrencyTransactions
-3925 usd
CY2023Q1 fil Fraud Loss Caused By Computer Hackers
FraudLossCausedByComputerHackers
0 usd
CY2022Q1 fil Fraud Loss Caused By Computer Hackers
FraudLossCausedByComputerHackers
-19400 usd
CY2023Q1 fil Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
136151 usd
CY2022Q1 fil Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-177216 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
164 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11809 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
149755 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-314894 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1114354 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-981975 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2078311 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-981975 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2078311 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
314920 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
492725 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-667055 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1585586 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2022Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
815000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-667055 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2400586 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12319522 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4013589 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4952287 usd
CY2023Q1 fil Series D Preferred Stock Issued For Cash Net Of Offering Cost
SeriesDPreferredStockIssuedForCashNetOfOfferingCost
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-317000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-10903 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-981975 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3642409 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3740303 usd
CY2022Q1 fil Series D Preferred Stock Issued For Cash Net Of Offering Cost
SeriesDPreferredStockIssuedForCashNetOfOfferingCost
815000 usd
CY2022Q1 fil Issuance Of Deemed Dividend In Dollars
IssuanceOfDeemedDividendInDollars
0 usd
CY2022Q1 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFees
2285656 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
15621 usd
CY2022Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-6563 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
0 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2078311 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4771706 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-667055 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1585586 usd
CY2023Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
-314920 usd
CY2022Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
-492725 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
60489 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
60489 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9781 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10557 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15621 usd
CY2023Q1 fil Amortization Of Debt Discount And Deferred Financing Costs
AmortizationOfDebtDiscountAndDeferredFinancingCosts
19541 usd
CY2022Q1 fil Amortization Of Debt Discount And Deferred Financing Costs
AmortizationOfDebtDiscountAndDeferredFinancingCosts
317840 usd
CY2023Q1 us-gaap Derivative Cost Of Hedge
DerivativeCostOfHedge
0 usd
CY2022Q1 us-gaap Derivative Cost Of Hedge
DerivativeCostOfHedge
16900 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
136151 usd
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-177216 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
149755 usd
CY2023Q1 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-1025660 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4225 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-23545 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40078 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31416 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30390 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-95313 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1900 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-19186 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
153843 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-266140 usd
CY2023Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-11582 usd
CY2022Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
0 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
29624 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
0 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4225 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
23544 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
70000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656496 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1071273 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4900 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4900 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
815000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
487123 usd
CY2022Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
381600 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
76250 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
154934 usd
CY2023Q1 us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
288378 usd
CY2022Q1 us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
336553 usd
CY2023Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
0 usd
CY2022Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
110000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-112375 usd
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
97430 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311120 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
573933 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-350276 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-497340 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
464248 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1093195 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
113972 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
595855 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 fil Issuance Of Common Stock Issued For Convertible Debt Loans Payable And Accrued Interest
IssuanceOfCommonStockIssuedForConvertibleDebtLoansPayableAndAccruedInterest
0 usd
CY2022Q1 fil Issuance Of Common Stock Issued For Convertible Debt Loans Payable And Accrued Interest
IssuanceOfCommonStockIssuedForConvertibleDebtLoansPayableAndAccruedInterest
1259996 usd
CY2023Q1 fil Deemed Dividend Upon Issuance Of Series D Preferred Stock
DeemedDividendUponIssuanceOfSeriesDPreferredStock
0 usd
CY2022Q1 fil Deemed Dividend Upon Issuance Of Series D Preferred Stock
DeemedDividendUponIssuanceOfSeriesDPreferredStock
815000 usd
CY2023Q1 fil Initial Amount Of Rou Asset And Related Liability Non Cash
InitialAmountOfRouAssetAndRelatedLiabilityNonCash
89830 usd
CY2022Q1 fil Initial Amount Of Rou Asset And Related Liability Non Cash
InitialAmountOfRouAssetAndRelatedLiabilityNonCash
0 usd
CY2023Q1 fil Initial Derivative Liability Recorded In Connection With Convertible Notes Payable
InitialDerivativeLiabilityRecordedInConnectionWithConvertibleNotesPayable
0 usd
CY2022Q1 fil Initial Derivative Liability Recorded In Connection With Convertible Notes Payable
InitialDerivativeLiabilityRecordedInConnectionWithConvertibleNotesPayable
76250 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Note 1 - Nature of Operations and Basis of Presentation</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Organization and Nature of Operations</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Bergio International, Inc. (the “Company”) was incorporated in the State of Delaware on July 24, 2007 under the name Alba Mineral Exploration, Inc. On October 21, 2009, as a result of a Share Exchange Agreement, the corporation’s name was changed to Bergio International, Inc. On February 19, 2020, the Company changed its state of incorporation to Wyoming. The Company is engaged in the product design, manufacturing, distribution of fine jewelry primarily in the United States and is headquartered in Fairfield, New Jersey. The Company’s intent is to take advantage of the Bergio brand and establish a chain of retail stores worldwide. The Company’s branded product lines are products and/or collections designed by the Company’s designer and CEO, Berge Abajian, and will be the centerpiece of the Company’s retail stores.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On February 10, 2021, the Company entered into an Acquisition Agreement (“Acquisition Agreement”) with Digital Age Business, Inc., a Florida corporation, (“Digital Age Business”), pursuant to which the shareholders of Digital Age Business agreed to sell all of the assets and liabilities of its Aphrodite’s business to a subsidiary of the Company known as Aphrodite’s Marketing, Inc. (“Aphrodite’s Marketing”), a Wyoming corporation in exchange for Series B Preferred Stock of the Company. The Company owns 51% of Aphrodite’s Marketing.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On July 1, 2021 (“Closing”), the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with GearBubble, Inc., a Nevada corporation, (“GearBubble”), pursuant to which the shareholders of GearBubble (the “Equity Recipients”) agreed to sell 100% of the issued and outstanding shares of GearBubble to a subsidiary of the Company known as GearBubble Tech, Inc. (“GearBubble Tech”), a Wyoming corporation in exchange for $3,162,000 (the “Cash Purchase Price”), which shall be paid as follows: a) $2,000,000 (which was paid in cash at Closing), b) $1,162,000 to be paid in 15 equal installments, and c) 49,000 of the 100,000 authorized shares of the Merger Sub, such that upon the Closing, 51% of the Merger Sub shall be owned by the Company, and 49% of the Merger Sub shall be owned by the GearBubble Shareholders. The Company owns 51% of GearBubble Tech.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On March 24, 2021, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation. The amendment reflected the increase in the authorized shares of common stock from 1,000,000,000 shares to 3,000,000,000 shares. On July 9, 2021, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation. The amendment reflected the increase in the authorized shares of common stock from 3,000,000,000 shares to 6,000,000,000 shares. On April 28, 2022, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 6,000,000,000 shares to 9,000,000,000 shares.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On September 26, 2022, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 9,000,000,000 shares to 15,000,000,000 shares. In March 2023, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 15,000,000,000 shares to 25,000,000,000 shares. In the same Articles of Amendment, the Company filed for a reverse split of the Company’s common stock, at the ratio of 1 for 500 (the “Reverse Stock Split”), which was declared effective by Financial Industry Regulatory Authority (“FINRA”) effective April 17, 2023. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the unaudited condensed consolidated financial statements to reflect the Reverse Stock Split.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">  </p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Basis of Presentation</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information, which includes consolidated interim financial statements and present the consolidated interim financial statements of the Company and its wholly-owned and majority-owned subsidiaries as of March 31, 2023. All intercompany transactions and balances have been eliminated. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows have been made. Those adjustments consist of normal and recurring adjustments. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2022, and footnotes thereto included in the Company’s Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2023 (the “Annual Report”). The results of operations for the three months ended March 31, 2023, are not necessarily indicative of the results to be expected for the full year.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Impact of the COVID-19 Coronavirus</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company’s operations have been affected by the recent and ongoing outbreak of the coronavirus disease 2019 (COVID-19) which in March 2020, was declared a pandemic by the World Health Organization. The ultimate disruption which may be caused by the outbreak is uncertain; however, it has resulted in a material adverse impact on the Company’s financial position, operations and cash flows. Areas affected include, but are not limited to, disruption to the Company’s customers and revenue, including a significant disruption in consumer demand and accessories, labor workforce, inability of customers to pay outstanding accounts receivable due and owing to the Company as they limit or shut down their businesses, customers seeking relief or extended payment plans relating to accounts receivable due and owing to the Company, unavailability of products and supplies used in operations, and the decline in value of assets held by the Company, including property and equipment. As such, the comparability of the Company’s operating results has been affected by significant adverse impacts related to the COVID-19 pandemic.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company has increased its online presence to minimize the impact of having to close its retail stores as well as directing efforts towards its wholesale operations. The Company increased its online presence through its majority-owned subsidiaries, Aphrodite’s Marketing and GearBubble Tech.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Non-controlling Interest in Consolidated Financial Statements</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">In December 2007, the Financial Accounting Standard Board (“FASB”) issued ASC 810-10-65, “Non-controlling Interests in consolidated financial statements, an amendment of Accounting Research Bulletin No. 51” (“SFAS No. 160”). This ASC clarifies that a non-controlling (minority) interest in a subsidiary is an ownership interest in the entity that should be reported as equity in the unaudited condensed consolidated financial statements. It also requires consolidated net income to include the amounts attributable to both the parent and non-controlling interest, with disclosure on the face of the consolidated income statement of the amounts attributed to the parent and to the non-controlling interest. In accordance with ASC 810-10- 45-21, those losses attributable to the parent and the non-controlling interest in subsidiaries may exceed their interests in the subsidiary’s equity. The excess and any further losses attributable to the parent and the non-controlling interest shall be attributed to those interests even if that attribution results in a deficit non-controlling interest balance.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On February 9, 2021, the Company entered into an Acquisition Agreement which resulted to the acquisition of 51% interest in Aphrodite’s Marketing. Additionally, on July 1, 2021, the Company entered into a Merger Agreement with GearBubble which resulted to the acquisition of 51% interest in the Merger Sub, GearBubble Tech. As of March 31, 2023 and December 31, 2022, the Company recorded a non-controlling interest balance of $(1,860,309) and $(1,545,389), respectively, in connection with the majority-owned subsidiaries, Aphrodite’s Marketing and GearBubble Tech as reflected in the accompanying unaudited condensed consolidated balance sheet and losses </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">attributable to non-controlling interest of $314,920 and $492,725 during the three months ended March 31, 2023 and 2022, respectively as reflected in the accompanying unaudited condensed consolidated statements of operations.</p>
CY2021Q1 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2021Q3 fil Total Selling Percentage
TotalSellingPercentage
1 pure
CY2021Q3 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
3162000 usd
CY2021Q3 fil Installment Description
InstallmentDescription
a) $2,000,000 (which was paid in cash at Closing), b) $1,162,000 to be paid in 15 equal installments, and c) 49,000 of the 100,000 authorized shares of the Merger Sub, such that upon the Closing, 51% of the Merger Sub shall be owned by the Company, and 49% of the Merger Sub shall be owned by the GearBubble Shareholders.
CY2021Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
3000000000 shares
CY2021Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
6000000000 shares
CY2022Q2 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
9000000000 shares
CY2022Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
15000000000 shares
CY2023Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
25000000000 shares
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 500 (the “Reverse Stock Split”), which was declared effective by Financial Industry Regulatory Authority (“FINRA”) effective April 17, 2023.
CY2021Q1 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2021Q3 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
314920 usd
CY2022Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
492725 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-667055 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656496 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20283316 usd
CY2023Q1 fil Working Capital Deficit
WorkingCapitalDeficit
1753346 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from estimates. Significant estimates during the three months ended March 31, 2023 and 2022 include the estimates of useful lives of property and equipment and intangible assets, valuation of the operating lease liability and related right-of-use asset, valuation of derivatives, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the fair value of warrants issued with debt, the valuation allowance on deferred tax assets, and stock-based compensation.</p>
CY2022Q4 fil Concentration Risk Percentage Accounts Receivable
ConcentrationRiskPercentageAccountsReceivable
0.90 pure
CY2023Q1 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Cost of revenues</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Cost of revenue consists primarily of the cost of the merchandise, shipping fees, credit card processing services, fulfillment cost, ecommerce sellers’ pay-out; costs associated with operation and maintenance of the Company’s platform.</p>
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
360180 usd
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
721104 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Reclassifications</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassified amounts have no impact on the Company’s previously reported financial position or results of operations and relates to the presentation of certain selling and marketing expenses previously included in cost of revenues.</p>
CY2023Q1 fil Total Derivative Liabilities
TotalDerivativeLiabilities
252659 usd
CY2022Q4 fil Total Derivative Liabilities
TotalDerivativeLiabilities
116508 usd
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Concentration Risk</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Revenues</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">For the three months ended March 31, 2023 and 2022, no customer accounted for over 10% of total revenues.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Purchases</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company purchased approximately 18% of its finished products from one vendor during the three months ended March 31, 2023. The Company purchased approximately 44% of its finished products from three vendors (15%, 19% and 10%) during the three months ended March 31, 2022.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Accounts Receivable</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">As of March 31, 2023, accounts receivable amounted to $127,200 and two customers represented 79% (44% and 35%) of this balance. As of December 31, 2022, total accounts receivable amounted to $119,931 and two customers represented 90% (60% and 30%) of this balance.</p>
CY2023Q1 fil Concentration Risk Percentage Purchases
ConcentrationRiskPercentagePurchases
0.18 pure
CY2022Q4 fil Concentration Risk Percentage Purchases
ConcentrationRiskPercentagePurchases
0.44 pure
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
127200 usd
CY2023Q1 fil Concentration Risk Percentage Accounts Receivable
ConcentrationRiskPercentageAccountsReceivable
0.79 pure
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
119931 usd
CY2023Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
391722 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
391722 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
581352 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
581352 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
8354 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
8354 usd
CY2023Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
25411 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20511 usd
CY2023Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1006839 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1001939 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
961556 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
951775 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45283 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50164 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9781 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10557 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18800301 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44215684 shares
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
79250 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
79250 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
40386 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
59926 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
38864 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
19324 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
252659 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
116508 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
978232 usd
CY2022Q1 fil Initial Valuation Of Derivative Liabilities Included In Debt Discount
InitialValuationOfDerivativeLiabilitiesIncludedInDebtDiscount
201250 usd
CY2022Q1 fil Initial Valuation Of Derivative Liabilities Related To Issuance Of Preferred Stock
InitialValuationOfDerivativeLiabilitiesRelatedToIssuanceOfPreferredStock
37706 usd
CY2022Q1 fil Initial Valuation Of Derivative Liabilities Included In Derivative Expense
InitialValuationOfDerivativeLiabilitiesIncludedInDerivativeExpense
-405700 usd
CY2022Q1 fil Reclassification Of Derivative Liabilities To Gain From Extinguishment Of Debt
ReclassificationOfDerivativeLiabilitiesToGainFromExtinguishmentOfDebt
-67284 usd
CY2022Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
627696 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
116508 usd
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
136151 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
252659 usd
CY2023Q1 fil Loans Principal Amount
LoansPrincipalAmount
938359 usd
CY2022Q4 fil Loans Principal Amount
LoansPrincipalAmount
839613 usd
CY2023Q1 fil Loans Payable Accrued Interest
LoansPayableAccruedInterest
344210 usd
CY2022Q4 fil Loans Payable Accrued Interest
LoansPayableAccruedInterest
232476 usd
CY2023Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
1282569 usd
CY2022Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
1072089 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
1080000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
962000 usd
CY2023Q1 fil Less Notes Payable Current Portion
LessNotesPayableCurrentPortion
-818656 usd
CY2022Q4 fil Less Notes Payable Current Portion
LessNotesPayableCurrentPortion
-702504 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
261344 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
259496 usd
CY2023Q1 fil Minimum Principal Payments Notes Payable
MinimumPrincipalPaymentsNotesPayable
1080000 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
33140 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
24465 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
23370 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
23484 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
20841 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4032 usd
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
129332 usd
CY2023Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19131 usd
CY2023Q1 fil Less Amounts Representing Interest Lease Payments
LessAmountsRepresentingInterestLeasePayments
110201 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
32216 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
77985 usd
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
100000000 shares
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021 fil Value Of Preferred Stock At Issuance Associated With The Acquisition In Shares
ValueOfPreferredStockAtIssuanceAssociatedWithTheAcquisitionInShares
5 shares
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
317000 usd
CY2023Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-10903 usd
CY2022Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-6563 usd
CY2021Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
3000000000 shares
CY2021Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
6000000000 shares
CY2022Q2 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
9000000000 shares
CY2022Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
15000000000 shares
CY2023Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
25000000000 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1596483 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.00
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1500000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.25
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.50
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
3095983 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.70
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
3095983 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.70
CY2023Q1 fil Number Of Warrants Exercisable
NumberOfWarrantsExercisable
3095983 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.70
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2023Q2 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees In Shares
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFeesInShares
600000 shares
CY2023Q2 fil Convertible Into Shares Of Common Fixed Price
ConvertibleIntoSharesOfCommonFixedPrice
0.006
CY2023Q2 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFees
3510 usd
CY2023Q2 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees In Shares
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFeesInShares
630973 shares
CY2023Q2 fil Convertible Into Shares Of Common Fixed Price
ConvertibleIntoSharesOfCommonFixedPrice
0.004
CY2023Q2 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFees
2524 usd

Files In Submission

Name View Source Status
brgo-20230331_cal.xml Edgar Link unprocessable
0001393905-23-000229-index-headers.html Edgar Link pending
0001393905-23-000229-index.html Edgar Link pending
0001393905-23-000229.txt Edgar Link pending
0001393905-23-000229-xbrl.zip Edgar Link pending
brgo-20230331.htm Edgar Link pending
brgo-20230331.xsd Edgar Link pending
brgo_ex311.htm Edgar Link pending
brgo_ex312.htm Edgar Link pending
brgo_ex321.htm Edgar Link pending
brgo_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
brgo-20230331_def.xml Edgar Link unprocessable
brgo-20230331_lab.xml Edgar Link unprocessable
brgo-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brgo-20230331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending